<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03654742</url>
  </required_header>
  <id_info>
    <org_study_id>T211/2018</org_study_id>
    <nct_id>NCT03654742</nct_id>
  </id_info>
  <brief_title>Intracapsular Tonsillectomy in Adults</brief_title>
  <official_title>Intracapsular vs Extracapsular Tonsillectomy. A Comparison of Treatment Methods of Recurrent and Chronic Tonsillitis in Adults: a Prospective Single-blinded Randomised Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Turku University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparing the classical extracapsular tonsillectomy performed with electrosurgery to
      intracapsular approaches by coblation or microdebrider.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Extracapsular tonsillectomy with monopolar electrosurgery is the most used approach in adult
      tonsil surgery in Turku University Central Hospital, Finland. In our study setting, the
      investigators wanted to challenge the status quo with the intracapsular approach done with
      either coblation or microdebrider, preserving the original indications of surgery as with the
      classical electrosurgery. Safety, efficiency and cost-effectiveness are monitored in a
      prospective, patient-blinded and randomised study setting.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 27, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>prospective, single-blinded, randomised</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Patients are masked with numbers and patient records not shown to the outcomes assessor</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative recovery</measure>
    <time_frame>21 days</time_frame>
    <description>Pain post-operatively at the ward measured by staff, and after discharge as self-reported pain intensity over the past day. Each day is scored with the modified Brief Pain Inventory and recovery is achieved when specified parameters score reaches preset values. Recovery speed defined as VAS-score 3 or less at rest; or VAS-score 5 or less without regular analgesics use. Daily questionnaire used: Brief Pain Inventory.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Analgesics use</measure>
    <time_frame>21 days</time_frame>
    <description>Need for analgesics postoperatively during 21 days. Measured as number of naprometin tablets/ day and the number of tramadol-paracetamol combination tablets/day.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative bleeding</measure>
    <time_frame>21 days</time_frame>
    <description>Bleeding post-operatively at the ward or at any point during 21 days. Measured as 1-4 (1= bleeding, stopped spontaneously, no contact with staff; 2: Check-up at ER, bleeding stopped without intervention; 3: Bleeding, needed intervention (packing, topical adrenalin, electrosurgical hemostasis; 4: Needed OR-time, blood transfusion, ward days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Life Quality</measure>
    <time_frame>6 months</time_frame>
    <description>Quality of life as defined by the questionnaires: Tonsillectomy Outcome Inventory 14 &quot;TOI-14&quot; preoperatively and 6 months after operation;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Residual tonsil tissue</measure>
    <time_frame>6 months</time_frame>
    <description>Residual tonsil measured right after surgery is completed and at 6 months follow-up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Revision surgery</measure>
    <time_frame>5 years</time_frame>
    <description>The need of revision surgery after tonsillectomy, recorded with questionnaire: Nordic Tonsil Surgery Register</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Throat problems</measure>
    <time_frame>5 years</time_frame>
    <description>Throat problems as described by the Nordic Tonsil Surgery Register at different time points postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Life quality</measure>
    <time_frame>6 months</time_frame>
    <description>Quality of life as defined by the questionnaires: Glasgow Benefit Inventory &quot;GBI&quot; at 6 months after operation.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Tonsil Disease</condition>
  <condition>Tonsillitis</condition>
  <condition>Tonsillitis Acute</condition>
  <condition>Tonsillitis Chronic</condition>
  <arm_group>
    <arm_group_label>ECTE/Electrosurgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Extracapsular tonsillectomy (ECTE) with monopolar electrosurgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ICTE/Microdebrider</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>(Total) Intracapsular tonsillectomy (ICTE) with microdebrider</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ICTE/Coblator</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>(Total) Intrapsular tonsillectomy (ICTE) with coblator</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>tonsillectomy</intervention_name>
    <description>removal of tonsil tissue as described in the study arms</description>
    <arm_group_label>ECTE/Electrosurgery</arm_group_label>
    <arm_group_label>ICTE/Coblator</arm_group_label>
    <arm_group_label>ICTE/Microdebrider</arm_group_label>
    <other_name>tonsil removal</other_name>
    <other_name>tonsil surgery</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 16-65 years

          -  Planned tonsil surgery with informed concent

          -  Recurrent or chronic tonsillitis

        Exclusion Criteria:

          -  Less than 1 month old, drained quinsy

          -  Acute &quot;hot phase&quot; tonsillitis

          -  Previous palatine tonsil surgery

          -  Suspicion or confirmation of malignancy

          -  High dose analgesics consumption

          -  Current CPAP-device usage for treatment of OSAS

          -  Untreated gastro-esophageal reflux disease

          -  Anticoagulative medication

          -  Any condition of hemophilia

          -  Pregnancy, lactation

          -  Current or positive history of malignant disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jussi Jero, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Turku University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tapani J. Uusitalo, M.D.</last_name>
    <phone>0405069070</phone>
    <phone_ext>+358</phone_ext>
    <email>uusitalotapani@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>TYKS Korvaklinikka</name>
      <address>
        <city>Turku</city>
        <zip>20521</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tapani J Uusitalo, MD</last_name>
      <phone>0405069070</phone>
      <phone_ext>+358</phone_ext>
      <email>uusitalotapani@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Jaakko Piitulainen, MD PhD</last_name>
      <phone>0408373612</phone>
      <phone_ext>+358</phone_ext>
      <email>jaakko.piitulainen@tyks.fi</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>August 29, 2018</study_first_submitted>
  <study_first_submitted_qc>August 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2018</study_first_posted>
  <last_update_submitted>September 30, 2019</last_update_submitted>
  <last_update_submitted_qc>September 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Turku University Hospital</investigator_affiliation>
    <investigator_full_name>Tapani Uusitalo</investigator_full_name>
    <investigator_title>Consultant</investigator_title>
  </responsible_party>
  <keyword>tonsil surgery</keyword>
  <keyword>tonsillectomy</keyword>
  <keyword>intracapsular</keyword>
  <keyword>microdebrider</keyword>
  <keyword>coblation</keyword>
  <keyword>extracapsular</keyword>
  <keyword>electrosurgery</keyword>
  <keyword>electrocautery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tonsillitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

